African Americans in Clinical Trials
Clinical trials are necessary for new medicines to be approved by the US Food and Drug Administration (FDA). They have played a major role in advancing the treatment of multiple myeloma. Without these trials and the patients who voluntarily participated in them, we would not have the treatment options we have today.
Having access to well-conducted clinical trials could help shrink health disparities
Many doctors think of clinical trials as another treatment option for multiple myeloma. But African Americans are less likely to have access to clinical trials and the potential benefits that come along with them, including:
- Possibly getting an investigational treatment for an illness when no other treatment exists
- Getting expert care for your condition
- Having early access to new treatments
In this video, Dr. Craig Cole talks about how clinical trials work, common myths regarding placebos, the potential risks and benefits of participating in a clinical trial, and more.
Where can I learn more about finding a clinical trial?
International Myeloma Foundation >
Multiple Myeloma Research Foundation >
Information about these independent organizations is provided as an additional resource for obtaining information related to multiple myeloma. It does not indicate endorsement by Bristol-Myers Squibb Company of an organization or its communications.
Your healthcare team is your best source of information.